Biogen, Sage Therapeutics Enter $1.5 Billion Deal To Develop, Sell Neurological Treatments

Biogen Inc will take a $650 million stake in Sage Therapeutics and pay $875 million in upfront payment as they jointly develop and sell treatments for neurological disorder, the two companies said on Friday.